Potential of radio-frequency balloon angioplasty: weld strengths, dose-response relationship, and correlative histology.
Previous studies have established the feasibility of combining tissue heat generated by radio-frequency (RF) current and mechanical pressure to manage problems of percutaneous transluminal angioplasty (PTA) that are thought to cause postangioplasty restenosis (PARS). In the current in vitro study of normal and atherosclerotic human aortic layers (intima-media and media-adventitia) separated artificially, the purposes were to identify a dose-response relationship between the total RF energy delivered and the resultant weld strength between vascular tissues and to study the histologic correlates. Twenty-eight control and 100 experimental specimens were evaluated. The mean weld strength for all specimens with no RF current (at 0 J) was 4.1 g +/- 2.0; at 100 J, 5.9 g +/- 2.8; at 200 J, 28.5 g +/- 3.3; at 300 J, 50.0 g +/- 5.5; and at 500 J, 82.0 g +/- 8.2. Inspection of treated specimens revealed vascular molding (depression in the surface corresponding in dimensions to those of the electrode gap in the treatment chamber). Histologic examination revealed necrosis in the region underlying the electrode gap, a hypocellular fusion zone, indistinct boundaries between welded specimen parts, and transition zones to normal histologic characteristics at either end of each specimen. RF energy combined with mechanical pressure produces dose-dependent thermal welds in artificially dissected vascular tissues, molding of vascular tissue, and cellular destruction in the media. These findings may have clinical application in the management or prevention of all forms of PARS in humans and in the treatment of spontaneous aortic dissection.
Becker
G J
GJ
Department of Radiology, Indiana University School of Medicine, Indianapolis 46223.
Lee
B I
BI
Waller
B F
BF
Barry
K J
KJ
Kaplan
J
J
Connolly
R
R
Dreesen
R G
RG
Nardella
P
P
D000800:Angioplasty, Balloon; D001011:Aorta / Q000473:pathology* / Q000503:physiopathology; D001018:Aortic Diseases / Q000473:pathology / Q000628:therapy; D001161:Arteriosclerosis / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D066298:In Vitro Techniques; D000078702:Radiofrequency Therapy; D013314:Stress, Mechanical